Clinical Trial Update: Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC [NA]

View source ↗

Summary

This clinical trial compares trough-level vancomycin dosing to AUC/MIC-guided dosing for serious methicillin-resistant Staphylococcus aureus infections in a non…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Methicillin-resistant Staphylococcus Aureus Infection

Drugs mentioned

• Vancomycin (vancomycin)

Snippet

Sponsor: Anthony Bai | Conditions: MRSA | NA | Status: RECRUITING